Pharmacokinetic Properties of Nalmefene in Subjects With Renal Impairment and in Healthy Subjects
NCT01934166
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
32
Enrollment
INDUSTRY
Sponsor class
Conditions
Renal Impairment
Interventions
DRUG:
Nalmefene 18 mg
Sponsor
H. Lundbeck A/S